ConditionsProstate cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- -
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men undergoing a PSMA PET
Exclusion Criteria
- •Unwillingness to participate in the registration study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
Active, Not Recruiting
Phase 1
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-001387-28-NLRadboud University Medical Center75
Completed
Phase 2
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathologyNL-OMON49534Radboud Universitair Medisch Centrum75
Not Yet Recruiting
N/A
Classification of risk groups of prostate cancer patients by using radiomics features in PSMA PET/CT images, which is done through a machine learning approach.Health Condition 1: C61- Malignant neoplasm of prostateCTRI/2023/07/055109Dept of nuclear medicine
Recruiting
N/A
Early Prostate cancer recurrence with PSMA PET positive unilateral pelvic lesion(s): is one-sided salvage extended lymph node dissection enough?C61Malignant neoplasm of prostateDRKS00020130Martini-Klinik am UKE GmbH397